Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-25
DOI
10.3389/fphar.2020.595219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs
- (2020) Katherine N. Theken et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Generating evidence for precision medicine
- (2020) Cathelijne H. van der Wouden et al. Pharmacogenetics and Genomics
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy
- (2019) Jacob T. Brown et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guideline for CYP 2B6 and Efavirenz‐containing Antiretroviral Therapy
- (2019) Zeruesenay Desta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
- (2019) Daniel M.F. Claassens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
- (2019) Kelly E. Caudle et al. CTS-Clinical and Translational Science
- Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
- (2019) Carin A. T. C. Lunenburg et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx
- (2018) Marie-Anne Loriot et al. BULLETIN DU CANCER
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
- (2018) Matthew P. Goetz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Information in Clinical Guidelines: The European Perspective
- (2018) Jesse J. Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
- (2018) Elizabeth J. Phillips et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study
- (2018) H. Maagdenberg et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- PharmGKB: A worldwide resource for pharmacogenomic information
- (2018) Julia M. Barbarino et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
- (2018) Britt I. Drögemöller et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
- (2018) Mary V. Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes
- (2018) Stephen G. Gonsalves et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database
- (2018) Reo Tanoshima et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Applications of pharmacogenomics in regulatory science: a product life cycle review
- (2017) W C Tan-Koi et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenetics of immunosuppressants: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics (RNPGx)
- (2017) Jean-Baptiste Woillard et al. THERAPIE
- Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx)
- (2017) Nicolas Picard et al. THERAPIE
- Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of Pharmacogenetics
- (2017) Sylvie Quaranta et al. THERAPIE
- Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx)
- (2017) Fabien Lamoureux et al. THERAPIE
- Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics
- (2017) Sylvie Quaranta et al. THERAPIE
- A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation
- (2016) N. Shuker et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
- (2016) Folefac Aminkeng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity – Ready for clinical practice?
- (2016) Didier Meulendijks et al. CANCER TREATMENT REVIEWS
- Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
- (2016) Kelly E. Caudle et al. GENETICS IN MEDICINE
- Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
- (2016) Jong W. Lee et al. THERAPEUTIC DRUG MONITORING
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forUGT1A1and Atazanavir Prescribing
- (2015) RS Gammal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing
- (2015) KA Birdwell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy
- (2015) Kaitlyn Shaw et al. THERAPEUTIC DRUG MONITORING
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype
- (2014) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
- (2014) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing
- (2014) K E Caudle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype
- (2014) J P Clancy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
- (2014) Kelly Caudle et al. CURRENT DRUG METABOLISM
- Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
- (2014) Ursula Amstutz et al. EPILEPSIA
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α–Based Regimens
- (2013) A J Muir et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology
- (2010) Colin J.D. Ross et al. THYROID
- Pharmacogenetics: From Bench to Byte
- (2008) JJ Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Joseph A. Church PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation